Trial intelligence / Profile preview

ZIO-201 in Advanced Sarcoma

NCT00439686Phase 2Completed

Sponsor
Alaunos Therapeutics
Start
Feb 2006
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of palifosfamide in sarcoma, sponsored by Alaunos Therapeutics. Started Feb 2006; status: completed.

02

Drugs

palifosfamide
03

Conditions

sarcoma

Beyond the preview

Go deeper on NCT00439686.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00439686.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call